{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:02:07Z","timestamp":1790679727996,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"vor","delay-in-days":817,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.14283\/jpad.2022.18","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T13:43:57Z","timestamp":1642686237000},"page":"480-490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cerebral Phospho-Tau Acts Synergistically with Soluble A\u03b242 Leading to Mild Cognitive Impairment in AAV-AD Rats"],"prefix":"10.1016","volume":"9","author":[{"given":"B.","family":"Souchet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Audrain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.F.","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.S.","family":"Orefice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Cartier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Janel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Braudeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.14283\/jpad.2022.18_bib1","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer's disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"5580","key":"10.14283\/jpad.2022.18_bib2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"issue":"13","key":"10.14283\/jpad.2022.18_bib3","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1016\/S0021-9258(17)38495-8","article-title":"Micro tubule-associated protein tau. A component of Alzheimer paired helical filaments","volume":"261","author":"Grundke-Iqbal","year":"1986","journal-title":"J Biol Chem"},{"issue":"1","key":"10.14283\/jpad.2022.18_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13195-017-0283-5","article-title":"On the path to 2025: understanding the Alzheimer's disease continuum","volume":"9","author":"Aisen","year":"2017","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"10.14283\/jpad.2022.18_bib5","doi-asserted-by":"crossref","first-page":"e0217026","DOI":"10.1371\/journal.pone.0217026","article-title":"Biomarker profiles of Alzheimer's disease and dynamic of the association between cerebrospinal fluid levels of beta-amyloid peptide and tau","volume":"14","author":"Lafirdeen","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.14283\/jpad.2022.18_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13195-020-00663-w","article-title":"Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval","volume":"12","author":"Tolar","year":"2020","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"10.14283\/jpad.2022.18_bib7","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/joim.12190","article-title":"Mild cognitive impairment: a concept in evolution","volume":"275","author":"Petersen","year":"2014","journal-title":"J Intern Med"},{"issue":"1","key":"10.14283\/jpad.2022.18_bib8","first-page":"e12026","article-title":"Prognostic value of ATN Alzheimer biomarkers: 60-month follow-up results from the Argentine Alzheimer's Disease Neuroimaging Initiative","volume":"12","author":"Allegri","year":"2020","journal-title":"Alzheimers Dement (Amst)"},{"issue":"ll","key":"10.14283\/jpad.2022.18_bib9","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"issue":"sl","key":"10.14283\/jpad.2022.18_bib10","doi-asserted-by":"crossref","first-page":"S567","DOI":"10.3233\/JAD-179941","article-title":"The Amyloid-beta Oligomer Hypothesis: Beginning of the Third Decade","volume":"64","author":"Cline","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"2\u20133","key":"10.14283\/jpad.2022.18_bib11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000353687","article-title":"Prefibrillar tau oligomers in mild cognitive impairment and Alzheimer's disease","volume":"13","author":"Mufson","year":"2014","journal-title":"Neurodegener Dis"},{"issue":"ll","key":"10.14283\/jpad.2022.18_bib12","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1093\/cercor\/bhx260","article-title":"betaAPP Processing Drives Gradual Tau Pathology in an Age-Dependent Amyloid Rat Model of Alzheimer's Disease","volume":"28","author":"Audrain","year":"2018","journal-title":"Cereb Cortex"},{"key":"10.14283\/jpad.2022.18_bib13","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05116","article-title":"Genomic mosaicism with increased amyloid precursor protein (APP) gene copy number in single neurons from sporadic Alzheimer's disease brains","volume":"4","author":"Bushman","year":"2015","journal-title":"Elife"},{"issue":"7733","key":"10.14283\/jpad.2022.18_bib14","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41586-018-0718-6","article-title":"Somatic APP gene recombination in Alzheimer's disease and normal neurons","volume":"563","author":"Lee","year":"2018","journal-title":"Nature"},{"key":"10.14283\/jpad.2022.18_bib15","doi-asserted-by":"crossref","DOI":"10.14283\/jpad.2021.67","article-title":"Evaluation of Memantine in AAV-AD Rat: A Model of Late-Onset Alzheimer's Disease Predementia","author":"Souchet","year":"2021","journal-title":"Journal of Prevention of Alzheimer's Disease"},{"issue":"48","key":"10.14283\/jpad.2022.18_bib16","doi-asserted-by":"crossref","first-page":"34850","DOI":"10.1074\/jbc.M707358200","article-title":"DYRKlA-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease","volume":"282","author":"Ryoo","year":"2007","journal-title":"J Biol Chem"},{"issue":"12","key":"10.14283\/jpad.2022.18_bib17","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1021\/jm200274d","article-title":"Leucettines, a class of potent inhibitors of cdc2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing","volume":"54","author":"Debdab","year":"2011","journal-title":"J Med Chem"},{"issue":"21","key":"10.14283\/jpad.2022.18_bib18","doi-asserted-by":"crossref","first-page":"9312","DOI":"10.1021\/jm301034u","article-title":"Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B","volume":"55","author":"Tahtouh","year":"2012","journal-title":"J Med Chem"},{"key":"10.14283\/jpad.2022.18_bib19","article-title":"Structure\/activity relationship in the Leucettine family of kinase inhibitors","author":"Tahtouh","year":"2021","journal-title":"J Med Chem"},{"issue":"1","key":"10.14283\/jpad.2022.18_bib20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40478-019-0678-6","article-title":"Inhibition of DYRK1A proteolysis modifies its kinase specificity and rescues Alzheimer phenotype in APP\/PS1 mice","volume":"7","author":"Souchet","year":"2019","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"10.14283\/jpad.2022.18_bib21","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.chembiol.2017.10.010","article-title":"Quantitative, Wide-Spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target Engagement","volume":"25","author":"Vasta","year":"2018","journal-title":"Cell Chem Biol"},{"issue":"7662","key":"10.14283\/jpad.2022.18_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/547153a","article-title":"Stop Alzheimer's before it starts","volume":"547","author":"McDade","year":"2017","journal-title":"Nature"},{"issue":"10","key":"10.14283\/jpad.2022.18_bib23","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1212\/WNL.0000000000001774","article-title":"Cognitive impairment 18 years before clinical diagnosis of Alzheimer disease dementia","volume":"85","author":"Rajan","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.14283\/jpad.2022.18_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer's disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10.14283\/jpad.2022.18_bib25","doi-asserted-by":"crossref","first-page":"e12179","DOI":"10.1002\/trc2.12179","article-title":"Alzheimer's disease drug development pipeline: 2021","volume":"7","author":"Cummings","year":"2021","journal-title":"Alzheimers Dement (N Y)"},{"issue":"4","key":"10.14283\/jpad.2022.18_bib26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.trci.2016.07.001","article-title":"Alzheimer's drug-development pipeline: 2016","volume":"2","author":"Cummings","year":"2016","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.14283\/jpad.2022.18_bib27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ebiom.2016.03.035","article-title":"The Role of Amyloid-beta Oligomers in Toxicity, Propagation, and Immunotherapy","volume":"6","author":"Sengupta","year":"2016","journal-title":"EBioMedicine"},{"issue":"14","key":"10.14283\/jpad.2022.18_bib28","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1523\/JNEUROSCI.0587-07.2007","article-title":"Accumulation of pathological tau species and memory loss in a conditional model of tauopathy","volume":"27","author":"Berger","year":"2007","journal-title":"J Neurosci"},{"issue":"2","key":"10.14283\/jpad.2022.18_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrneurol.2015.251","article-title":"Suspected non-Alzheimer disease pathophysiology\u2014concept and controversy","volume":"12","author":"Jack","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"S1","key":"10.14283\/jpad.2022.18_bib30","first-page":"S2","article-title":"Abstract: Symposia, Conferences, Oral communications: 14th Clinical Trials on Alzheimer's Disease (CTAD) November 9\u201312, 2021","volume":"8","year":"2021","journal-title":"J Prev Alzheimers Dis"},{"issue":"3","key":"10.14283\/jpad.2022.18_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/jpm10030085","article-title":"Current Biomarkers for Alzheimer's Disease: From CSF to Blood","volume":"10","author":"Zou","year":"2020","journal-title":"J Pers Med"},{"issue":"4","key":"10.14283\/jpad.2022.18_bib32","first-page":"313","article-title":"Healthy Aging Biomarkers: The INSPIRE's Contribution","volume":"10","author":"Ader","year":"2021","journal-title":"J Frailty Aging"}],"updated-by":[{"DOI":"10.1007\/s12603-022-1779-7","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000}},{"DOI":"10.14283\/jpad.2022.74","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000}}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724003066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724003066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:42:51Z","timestamp":1736469771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724003066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2274580724003066"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2022.18","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebral Phospho-Tau Acts Synergistically with Soluble A\u03b242 Leading to Mild Cognitive Impairment in AAV-AD Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2022.18","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2022.74","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}